Logo medicamento Friracil

Therapeutic action

Antineoplastic, antimetabolites

Indications

Metastatic colorectal cancer

Presentation

Coated tablets of 15 mg/6,14 mg, 20 mg/8,19 mg, 15 mg/6,14 mg y 20 mg/8,19 mg